Taking the next steps in the treatment of Alzheimer's disease: disease-modifying agents.
Stephen
S
Salloway
D000544:Alzheimer Disease / Q000188:drug therapy*; D016229:Amyloid beta-Peptides / Q000037:antagonists & inhibitors; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D005480:Flurbiprofen / Q000627:therapeutic use; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use
D016229:Amyloid beta-Peptides; D000894:Anti-Inflammatory Agents, Non-Steroidal; D018696:Neuroprotective Agents; D005480:Flurbiprofen